Hedge Fund Manager Turned Pharmaceutical CEO Turned Public Enemy Number One Reminds Object Of Affection Offer To "Smash That" Won't Last Long - Dealbreaker

Hedge Fund Manager Turned Pharmaceutical CEO Turned Public Enemy Number One Reminds Object Of Affection Offer To "Smash That" Won't Last Long

Martin Shkreli's romantic overtures have an expiration date.

Author:: Bess Levin
Updated:: Jan 14, 2019
Original:: Dec 9, 2015

Apparently Taylor Swift means nothing to him.

Related: Ex-Hedge Fund Manager Turned Pharmaceutical CEO Doesn’t See The Big Deal Charging $750 Today For Life-Saving Drug That Cost $13.50 Yesterday; Martin Shkreli-Funded Record Label Would Rather Fold Than Take Another Dollar From Martin Shkreli; Hedge Fund Manager Turned Pharma CEO Martin Shkreli May Be A D*ck For Reasons Previously Unknown: NY Attorney General Hedge Fund Manager Turned Pharma CEO Turned Public Enemy Number One Has An Exciting Opportunity For You And 19 Of Your Closest Friends; Hedge Fund Manager Turned Pharma CEO Turned Public Enemy Number One Seeks Music Producers “With Real Grimy Beats”; Martin Shkreli Still Doesn’t Get The Fuss Over His Business Model; Big Pharma CEOs: Even We Think Martin Shkreli Is Pretty Awful; Emo Bro Martin Shkreli Blows $2 Million On Sole Copy Of New Wu Tang Clan Album Because He Is Desperate To Bang Taylor Swift

Martin Shkreli is trying his hand at rap.

Who wants to work for Martin Shkreli?

Martin Shkreli is fighting haters on multiple fronts.

Martin Shkeli is surprised and hurt by the hate.

This is the one everyone's been waiting for: the Martin Shkreli endorsement.

ShkreliTheMusical

We have Act 3 of "Martin Shkreli's Game"

Martin Shkreli is still playing dates on his "Unrepentant A$$hole" Tour.

Meet Mike Kulich.